We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Celanese's Earnings and Revenues Surpass Estimates in Q4
Read MoreHide Full Article
Celanese Corporation (CE - Free Report) reported fourth-quarter 2024 loss from continuing operations of $17.45 per share. This is in contrast to earnings of $6.43 in the prior-year quarter.
Adjusted earnings in the fourth quarter were $1.45 per share, down from $2.24 reported a year ago. The bottom line topped the Zacks Consensus Estimate of $1.20.
Find the latest earnings estimates and surprises on Zacks Earnings Calendar.
Revenues of $2,370 million fell roughly 8% year over year. It, however, beat the Zacks Consensus Estimate of $2,300 million.
Celanese experienced sustained demand weakness in major end markets during the reported quarter. Fourth-quarter results were also affected by sequential seasonality in the Acetyl Chain unit and significant Western Hemisphere automotive and industrial destocking in the Engineered Materials segment. CE took actions to cut costs, align production to available demand and release working capital through inventory drawdown to lessen the impact of the demand weakness in the reported quarter.
Celanese Corporation Price, Consensus and EPS Surprise
Net sales in the Engineered Materials unit were $1,281 million in the quarter, down around 9% year over year. It missed our estimate of $1,307.6 million. The segment reported an operating loss of $1,508 million compared with a profit of $122 million a year ago.
The Acetyl Chain segment posted net sales of $1,110 million, down around 6% year over year. It beat our estimate of $1,039.3 million. The segment generated an operating profit of $216 million, down from $264 million a year ago.
CE’s FY24 Results
Loss (as reported) for full-year 2024 was $13.86 per share. This is in contrast to earnings of $18 per share a year ago. Net sales fell around 6% year over year to $10.3 billion on lower volumes and prices.
Celanese’s Financials
Celanese ended the quarter with cash and cash equivalents of $962 million, down roughly 47% year over year. Long-term debt was down around 10% year over year to $11,078 million.
Cash provided by operating activities was $966 million and free cash flow was $498 million in 2024.
CE’s Outlook
Celanese anticipates the demand and pricing challenges experienced in the fourth quarter compared with the third quarter to persist in the first quarter of 2025. It sees continued softness in core end-markets such as automotive, construction, paints, coatings and industrial. CE also expects additional headwinds from seasonality in acetate tow and medical implants businesses as well as a planned outage at the Bishop, TX, facility in the first quarter.
Celanese expects first-quarter earnings per share in the band of 25-50 cents including the impact of non-recurring costs.
CE’s Stock Price Performance
Celanese’s shares have lost 53.7% in the past year against the Zacks Chemicals Specialty industry’s 17.8% decline.
Image Source: Zacks Investment Research
CE’s Zacks Rank & Other Key Picks
CE currently carries a Zacks Rank #5 (Strong Sell).
ICL Group is slated to release fourth-quarter results on Feb.26. The consensus estimate for ICL’s fourth-quarter earnings is pegged at 6 cents. It surpassed the Zacks Consensus Estimate for earnings in each of the last four quarters at an average of 18.1%.
Compania de Minas Buenaventura is scheduled to release fourth-quarter results on Feb. 20. The Zacks Consensus Estimate for BVN’s fourth-quarter earnings is pegged at 20 cents.
Kronos Worldwide is expected to release fourth-quarter results on March 5. The Zacks Consensus Estimate for KRO’s fourth-quarter earnings is pegged at 11 cents. KRO has gained around 4% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Celanese's Earnings and Revenues Surpass Estimates in Q4
Celanese Corporation (CE - Free Report) reported fourth-quarter 2024 loss from continuing operations of $17.45 per share. This is in contrast to earnings of $6.43 in the prior-year quarter.
Adjusted earnings in the fourth quarter were $1.45 per share, down from $2.24 reported a year ago. The bottom line topped the Zacks Consensus Estimate of $1.20.
Find the latest earnings estimates and surprises on Zacks Earnings Calendar.
Revenues of $2,370 million fell roughly 8% year over year. It, however, beat the Zacks Consensus Estimate of $2,300 million.
Celanese experienced sustained demand weakness in major end markets during the reported quarter. Fourth-quarter results were also affected by sequential seasonality in the Acetyl Chain unit and significant Western Hemisphere automotive and industrial destocking in the Engineered Materials segment. CE took actions to cut costs, align production to available demand and release working capital through inventory drawdown to lessen the impact of the demand weakness in the reported quarter.
Celanese Corporation Price, Consensus and EPS Surprise
Celanese Corporation price-consensus-eps-surprise-chart | Celanese Corporation Quote
CE’s Segment Highlights
Net sales in the Engineered Materials unit were $1,281 million in the quarter, down around 9% year over year. It missed our estimate of $1,307.6 million. The segment reported an operating loss of $1,508 million compared with a profit of $122 million a year ago.
The Acetyl Chain segment posted net sales of $1,110 million, down around 6% year over year. It beat our estimate of $1,039.3 million. The segment generated an operating profit of $216 million, down from $264 million a year ago.
CE’s FY24 Results
Loss (as reported) for full-year 2024 was $13.86 per share. This is in contrast to earnings of $18 per share a year ago. Net sales fell around 6% year over year to $10.3 billion on lower volumes and prices.
Celanese’s Financials
Celanese ended the quarter with cash and cash equivalents of $962 million, down roughly 47% year over year. Long-term debt was down around 10% year over year to $11,078 million.
Cash provided by operating activities was $966 million and free cash flow was $498 million in 2024.
CE’s Outlook
Celanese anticipates the demand and pricing challenges experienced in the fourth quarter compared with the third quarter to persist in the first quarter of 2025. It sees continued softness in core end-markets such as automotive, construction, paints, coatings and industrial. CE also expects additional headwinds from seasonality in acetate tow and medical implants businesses as well as a planned outage at the Bishop, TX, facility in the first quarter.
Celanese expects first-quarter earnings per share in the band of 25-50 cents including the impact of non-recurring costs.
CE’s Stock Price Performance
Celanese’s shares have lost 53.7% in the past year against the Zacks Chemicals Specialty industry’s 17.8% decline.
Image Source: Zacks Investment Research
CE’s Zacks Rank & Other Key Picks
CE currently carries a Zacks Rank #5 (Strong Sell).
Better-ranked stocks in the Basic Materials space are ICL Group Ltd (ICL - Free Report) , Compania de Minas Buenaventura S.A.A. (BVN - Free Report) and Kronos Worldwide, Inc. (KRO - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
ICL Group is slated to release fourth-quarter results on Feb.26. The consensus estimate for ICL’s fourth-quarter earnings is pegged at 6 cents. It surpassed the Zacks Consensus Estimate for earnings in each of the last four quarters at an average of 18.1%.
Compania de Minas Buenaventura is scheduled to release fourth-quarter results on Feb. 20. The Zacks Consensus Estimate for BVN’s fourth-quarter earnings is pegged at 20 cents.
Kronos Worldwide is expected to release fourth-quarter results on March 5. The Zacks Consensus Estimate for KRO’s fourth-quarter earnings is pegged at 11 cents. KRO has gained around 4% in the past year.